UK approves Pfizer and Biontech coronavirus vaccine, to be available from next week

Dhwani Mehta FXStreet

The Medicines and Healthcare Products Regulatory Agency (MHRA), the UK’s medical regulator, gave a green signal to the coronavirus vaccine co-developed by BioNTech SE and Pfizer Inc on Wednesday, concluding it’s both safe and effective.

The vaccine will be available in the UK from next week.

The UK joint committee confirmed the approval of the vaccine, adding that they will shortly publish its final advice for the vaccine distribution.

The Health Minister Matt Hancock was quick to respond, “this is fantastic news from the regulator on the Pfizer vaccine.”

Additional comments

“NHS stands ready, will start vaccinating next week.”

“This will be a challenging rollout due to specifics of storage.”

“We have plans in place to deal with those specifics.”

“We're expecting millions of doses for the whole of the UK by the end of the year.”

Market reaction

The above announcement was well-anticipated and failed to have any big market-moving impact. Although the S&P 500 futures trimmed losses while GBP/USD held onto mild gains around 1.3420.

Author

Dhwani Mehta

FXStreet

Residing in Mumbai (India), Dhwani is a Senior Analyst and Manager of the Asian session at FXStreet. She has over 10 years of experience in analyzing and covering the global financial markets, with specialization in Forex and commodities markets.

GBP/USD extends the drop to 1.3360

GBP/USD builds on Monday’s decline and briefly clinches five-day lows near 1.3360 on Tuesday. Cable’s extra pullback follows the better tone in the Greenback as uncertainty in the Middle East prompts investors to adopt a cautious stance. Meanwhile, an apathetic UK labour market report also collaborates with the selling pressure on the British Pound.

EUR/USD stays offered just above 1.1400

EUR/USD keeps the downtrend well in place for yet another day, challenging the 1.1400 contention zone on Tuesday. The continuation of the selling impulse in spot comes amid decent gains in the US Dollar, which continues to find support in the persistent effervescence surrounding the US-Iran crisis.

Gold hits one-week high, near $4,100 as bulls shrug off Fed hike bets and firmer USD

Gold advances to an over one-week high during the Asian session on Wednesday, with bulls now awaiting a move beyond $4,100 before positioning for additional gains. However, concerns about energy-driven inflation risks continue to fuel Fed rate-hike bets and act as a tailwind for the US Dollar amid escalating US-Iran tensions, which, in turn, could cap the bullion.

XRP rebounds on rising on-chain activity

Ripple (XRP) ticks up and trades around $1.13 at the time of writing on Tuesday. This rebound aligns with a broader recovery in the cryptocurrency market, attributed to reports that mediators between the United States (US) and Iran are seeking a 10-day cessation of strikes to find a way back to the signed Memorandum of Understanding (MoU).

The Iranian war has again risen

The Iranian war has again risen to the top of the economics factor list. There is no end in sight. Intelligence experts say the current level of offense/retaliation will not change minds in Tehran, while in Washington, Trump fears all-out war, which would mean boots on the ground.

US Dollar mid-year outlook: Exceptional currency, exceptional risks?

The US Dollar enters the second half of 2026 in a markedly different position from a year ago. The King currency has recovered, reflecting persistent US inflation, changing expectations for Fed policy, geopolitical tensions and renewed demand for defensive assets.